Transcatheter heart valves technologies

Functional and structural reverse myocardial remodeling following transcatheter aortic valve replacement: a prospective cardiovascular magnetic resonance study

Published on 18/08/2022 | Lange Torben 1 et al. | Journal of Cardiovascular Magnetic Resonance 2022; 24(1): 45 | 27 minute read

Abstract Background Since cardiovascular magnetic resonance (CMR) imaging allows comprehensive quantification of both myocardial function and structure we aimed to

Transcatheter heart valves technologies

Transcatheter Mitral Valve Replacement in High-Surgical Risk Patients: A Single-Center Experience and Outcome

Published on 04/08/2022 | Taha Fatma A. 1 et al. | Journal of interventional cardiology 2022 (2022), Article ID 6587036, 17 pages | 35 minute read

Abstract Background Re-operative mitral valve (MV) replacement is a high-risk procedure, therefore, transcatheter MV replacement (TMVR) is a promising therapeutic

Transcatheter heart valves technologies

Clinical Factors and Outcomes When Real-World Heart Teams Overruled STS Risk Scores in TAVR Cases

Published on 21/07/2022 | King Jackson M. 1 et al. | Journal of interventional cardiology 2022 (2022), Article ID 9926423, 9 pages | 20 minute read

Abstract Objectives This study was conducted to determine why heart teams recommended transcatheter aortic valve replacement (TAVR) versus surgical AVR

Transcatheter heart valves technologies

Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis

Published on 21/07/2022 | Francesco Cannata 1 et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.13876 | 22 minute read

Abstract Aims Aortic stenosis (AS) and cardiac amyloidosis (CA) are typical diseases of the elderly. Up to 16% of older

Transcatheter heart valves technologies

Transcatheter tricuspid valve intervention techniques and procedural steps for the treatment of tricuspid regurgitation: a review of the literature

Published on 07/07/2022 | Kamal Matli 1 et al. | Open Heart 2022; 9(1): e002030 | 32 minute read

Abstract Severe tricuspid regurgitation (TR) is an undertreated common pathology associated with significant morbidity and mortality. Classically, surgical repair or

Transcatheter heart valves technologies

Safety and efficacy of transcatheter mitral valve repair in patients with COPD; results from real‐world cohort

Published on 16/06/2022 | Mhd Nawar AlachkarMD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30238 | 16 minute read

Abstract Objective To evaluate the safety and efficacy of transcatheter mitral valve repair (TMVR) in patients with chronic obstructive pulmonary

Transcatheter heart valves technologies

Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation

Published on 16/06/2022 | van Nieuwkerk et al. | The American Journal of Cardiology 2022; 172(1 June 2022): 81-9 | 0 minute read

Transcatheter heart valves technologies

Carotid ultrasound following Transcarotid Transcatheter aortic valve replacement

Published on 02/06/2022 | Panagides et al. | International Journal of Cardiology 2022; 358(1 July 2022): 12-6 | 0 minute read

Transcatheter heart valves technologies

Financial Incentives for Transcatheter Aortic Valve Implantation in Ontario, Canada: A Cost‐Utility Analysis

Published on 19/05/2022 | John K. Peel MD 1 et al. | Journal of the American Heart Association 2022; 11(8): 025085 | 31 minute read

Abstract Background Transcatheter aortic valve implantation (TAVI) is a minimally invasive therapy for patients with severe aortic stenosis, which has

Transcatheter heart valves technologies

Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study

Published on 19/05/2022 | Kawakami et al. | Circulation: Cardiovascular Interventions 2022; 15(4): e011358 | 8 minute read

Indications for transcatheter aortic valve replacement (TAVR) have expanded to aortic stenosis patients with low- and intermediate-risk of surgery.1 Post-TAVR

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.